Contactless Measurement of Heart Rate, Heart Rate Variability and Breathing Rate Using Remote Photoplethysmography

NCT ID: NCT05889832

Last Updated: 2024-03-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

136 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-04-26

Study Completion Date

2023-06-06

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study it to evaluate the accuracy of heart rate, heart rate variability and breathing rate measurement with the use of Shen.AI Vitals software developed by MX Labs.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Resting heart rate (HR), heart rate variability (HRV) and breathing rate (BR) will be measured (estimated) with the use of remote photoplethysmography (1-minute face video analysis with Shen.AI Vitals software).

The measurements will be taken with various camera-equipped devices (smartphones, tablets, laptops) using either front camera (self-measurement) or rear camera (measurement made by someone else), in two different lighting conditions (artificial light or natural daylight), with various levels of device stability (fully stable or held in hand/s), and in two different body positions (sitting or supine). In total, each participant will have 8 measurements taken.

Standard deviation of normal heartbeat intervals (SDNN) will be used as the main HRV index.

Apart from the average HR (averaged over the whole 1-minute measurement), instantaneous values of HR (averaged over 10 s) will also be determined and displayed every 1 s by the Shen.AI VItals software.

In all cases, reference measurements will be taken simultaneously (chest ECG for the calculation of average and instantaneous HR as well as HRV; impedance pneumography for the determination of BR).

The reference measurements will be taken with Finapres Nova with the ECG+Resp module (Finapres Medical Systems B.V.).

For each measured parameter, the results from both methods will be compared using the Bland-Altman analysis or non-parametric limits of agreement.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Heart Rate Heart Rate Variability Respiratory Rate

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

HR, HRV and BR measured with Shen.AI and reference method

Group Type EXPERIMENTAL

measurement of physiological parameters wih Shen.AI Vitals software on various camera-equipped devices (smartphones, tablets, laptops)

Intervention Type DIAGNOSTIC_TEST

Resting heart rate (HR), heart rate variability (HRV) and breathing rate (BR) will be measured (estimated) with the use of remote photoplethysmography (1-minute face video analysis with Shen.AI Vitals software).

Reference measurements will be taken simultaneously (chest ECG for the calculation of HR and HRV; impedance pneumography for BR).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

measurement of physiological parameters wih Shen.AI Vitals software on various camera-equipped devices (smartphones, tablets, laptops)

Resting heart rate (HR), heart rate variability (HRV) and breathing rate (BR) will be measured (estimated) with the use of remote photoplethysmography (1-minute face video analysis with Shen.AI Vitals software).

Reference measurements will be taken simultaneously (chest ECG for the calculation of HR and HRV; impedance pneumography for BR).

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age ≥ 18 years
* ability to read and write in Polish or English
* ability to operate a smartphone, tablet and laptop without the need for glasses
* ability to understand the study procedure
* ability to communicate and follow the instructions of the study staff
* written consent to participate in the study and to the processing of personal data by the research team and the sponsor of the study

Exclusion Criteria

* failure to provide the required information in the participant's information survey
* failure to comply with the study procedure or the instructions of the study stuff
* extensive facial skin damage (including abrasions, wounds, burns)
* a disease process involving a large part of the face that makes the video- based measurement impossible
* extensive face dressing
* extensive facial skin tattoo or face painting
* marked deformation of the face (e.g. a tumor)
* inability to keep the head stable in the required position during the measurement
* persistent cough making it impossible to remain still during the measurement
* respiratory dysfunction in the form of shortness of breath or irregular or shallow breathing
* diagnosed arrhythmia (except sinus bradycardia or tachycardia)
* moderate or severe anemia
* diagnosed: heart failure, left ventricular systolic dysfunction, aortic stenosis or other diseases or disorders within the heart vascular system leading to decreased stroke volume, low pressure amplitude or the so-called paradoxical pulse
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

SHEN.AI spółka z ograniczoną odpowiedzialnością oddział w Polsce

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bartłomiej Paleczny

Role: PRINCIPAL_INVESTIGATOR

Wrocław Medical University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Uniwersyteckie Centrum Wsparcia Badań Klinicznych we Wrocławiu

Wroclaw, Lower Silesian Voivodeship, Poland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Poland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MDF-01-008-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Vis-Rx Post-Market Evaluation
NCT04533503 COMPLETED